CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
Yingjun X, Yuhuan X, Yuchang C, Dongzhi L, Ding W, Bing S, Yi Y, Dian L, Yanting X, Zeyu X, Nengqing L, Diyu C, Xiaofang S.
Yingjun X, et al. Among authors: ding w.
Ann Hematol. 2019 Dec;98(12):2661-2671. doi: 10.1007/s00277-019-03763-2. Epub 2019 Sep 9.
Ann Hematol. 2019.
PMID: 31495903
Free PMC article.